In light of the high frequency of ATP6AP1 and ATP6AP2 inactivating mutations in GCTs, which suggests a putative tumor suppressor role for these genes, we hypothesized that their loss of function would result in the acquisition of oncogenic properties in vitro in GCT-relevant cell models. The gene discussed is ATP6AP1; the disease is neoplasm.